Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan

November 4, 2010 By Bio-Medicine.Org

MISSISSAUGA, Ontario, Nov. 4, 2010 /PRNewswire-FirstCall/ —
Valeant Pharmaceuticals International, Inc. (NYSE:
VRX
) (TSX: VRX) today announced that the Company’s Board of
Directors (the “Board”) has declared a one-time special dividend of
US$1.00 per common share (the “Special Dividend”) that shareholders
of record as of the close of business on November 15, 2010 (the
“Record Date”) will be entitled to receive on December 22, 2010.
 The Board declared the Special Dividend in connection with
the consummation, on September 28, 2010, of the previously
announced merger of Valeant Pharmaceuticals International and
Biovail Corporation.  After payment of the Special Dividend,
the Company does not expect to pay dividends in the future.

In addition, the Board has approved the establishment of a
Special Dividend Reinvestment Plan (the “Plan”), which will enable
eligible shareholders to elect to reinvest the Special Dividend
(net of any applicable withholding tax) in additional common shares
of the Company ( the “Common Shares”).  Only Canadian and
United States residents who are shareholders of record as of the
Record Date will be eligible to participate in the Plan.

The Plan is being created solely for use in connection with the
Special Dividend and will only be used for this one-time purpose.
 The Plan will automatically terminate on December 22, 2010,
immediately following payment of the Special Dividend.  

Before enrolling, eligible shareholders are advised to read the
complete text of the Plan and to consult their financial advisers
regarding their unique investment profile and tax situation.

CIBC Mellon Trust Company (the “Agent”) has been appointed as
the agent to administer the Plan.  Shareholders of record as
of the Record Date will receive by mail the Plan and enrollment
form, as well as the registration statement on Form S-

‘/>”/>

SOURCE

Related Articles Read More >

Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech